Ionis Pharmaceuticals, Inc.
IONS
$72.33
-$0.01-0.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -229.39M | -128.61M | 123.55M | -146.94M | -104.35M |
| Total Depreciation and Amortization | 7.34M | 4.50M | 5.45M | 5.40M | 5.27M |
| Total Amortization of Deferred Charges | 1.97M | 1.65M | 1.65M | 1.64M | 1.67M |
| Total Other Non-Cash Items | 58.52M | -3.57M | 49.17M | 30.30M | 42.65M |
| Change in Net Operating Assets | 23.86M | -5.41M | -28.48M | -41.18M | -61.39M |
| Cash from Operations | -137.71M | -131.44M | 151.34M | -150.78M | -116.14M |
| Capital Expenditure | -21.29M | -5.27M | -12.31M | -12.58M | -25.50M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -398.21M | 96.61M | -107.76M | 183.04M | 93.71M |
| Cash from Investing | -419.51M | 91.34M | -120.07M | 170.46M | 68.21M |
| Total Debt Issued | 770.00M | -- | -- | -- | -- |
| Total Debt Repaid | -267.69M | -41.00K | -40.00K | -42.00K | -44.55M |
| Issuance of Common Stock | 107.82M | 81.26M | 1.29M | 2.24M | 429.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.95M | -- | -- | -- | -- |
| Cash from Financing | 591.18M | 81.22M | 1.25M | 2.20M | -44.12M |
| Foreign Exchange rate Adjustments | -43.00K | -82.00K | 595.00K | 232.00K | -486.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.92M | 41.04M | 33.11M | 22.12M | -92.53M |